Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Consuelo Pedrós

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Medicina Clinica|April 12, 2002
[First spontaneous reports of adverse reactions to the new selective COX-2 non-steroidal anti-inflammatory drugs]Consuelo Pedrós, Gloria Cereza, Joan-Ramon Laporte
Drug Safety|July 3, 2002
Therapeutic ineffectiveness: heads or tails?Albert Figueras, Consuelo Pedrós, Mabel Valsecia, et al.
European Journal of Clinical Pharmacology|November 8, 2015
Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main featuresConsuelo Pedrós, Francesc Formiga, Xavier Corbella, et al.
Drug Safety|February 1, 2002
Case-population studies in pharmacoepidemiologyDolors Capellà, Consuelo Pedrós, Xavier Vidal, et al.
BMC Nephrology|June 1, 2019
Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease: study protocol for a multicenter population-based case-control study using health databasesConsuelo Pedrós, Mónica Ávila, Ainhoa Gómez-Lumbreras, et al.
Drug Safety|October 30, 2003
Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription padsJosep Maria Castel, Albert Figueras, Consuelo Pedrós, et al.
The Annals of Pharmacotherapy|July 6, 2012
Levetiracetam-induced drug reaction with eosinophilia and systemic symptoms syndromeSilvia Gómez-Zorrilla, Antonio Vallano Ferraz, Consuelo Pedrós, et al.
European Journal of Clinical Pharmacology|December 24, 2013
Prevalence, risk factors and main features of adverse drug reactions leading to hospital admissionConsuelo Pedrós, Beatriz Quintana, Mireia Rebolledo, et al.
Gaceta Sanitaria|December 14, 2011
[Systematic review of studies assessing the cost of adverse drug reactions]Antonio Vallano Ferraz, Antonia Agustí Escasany, Consuelo Pedrós Xolvi, et al.
BMC Research Notes|November 19, 2010
Educational sessions in pharmacovigilance: What do the doctors think?Antonio Vallano, Consuelo Pedrós, Antonia Agustí, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Medicina Clinica|April 12, 2002
[First spontaneous reports of adverse reactions to the new selective COX-2 non-steroidal anti-inflammatory drugs]Consuelo Pedrós, Gloria Cereza, Joan-Ramon Laporte
Drug Safety|July 3, 2002
Therapeutic ineffectiveness: heads or tails?Albert Figueras, Consuelo Pedrós, Mabel Valsecia, et al.
European Journal of Clinical Pharmacology|November 8, 2015
Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main featuresConsuelo Pedrós, Francesc Formiga, Xavier Corbella, et al.
Drug Safety|February 1, 2002
Case-population studies in pharmacoepidemiologyDolors Capellà, Consuelo Pedrós, Xavier Vidal, et al.
BMC Nephrology|June 1, 2019
Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease: study protocol for a multicenter population-based case-control study using health databasesConsuelo Pedrós, Mónica Ávila, Ainhoa Gómez-Lumbreras, et al.
Drug Safety|October 30, 2003
Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription padsJosep Maria Castel, Albert Figueras, Consuelo Pedrós, et al.
The Annals of Pharmacotherapy|July 6, 2012
Levetiracetam-induced drug reaction with eosinophilia and systemic symptoms syndromeSilvia Gómez-Zorrilla, Antonio Vallano Ferraz, Consuelo Pedrós, et al.
European Journal of Clinical Pharmacology|December 24, 2013
Prevalence, risk factors and main features of adverse drug reactions leading to hospital admissionConsuelo Pedrós, Beatriz Quintana, Mireia Rebolledo, et al.
Gaceta Sanitaria|December 14, 2011
[Systematic review of studies assessing the cost of adverse drug reactions]Antonio Vallano Ferraz, Antonia Agustí Escasany, Consuelo Pedrós Xolvi, et al.
BMC Research Notes|November 19, 2010
Educational sessions in pharmacovigilance: What do the doctors think?Antonio Vallano, Consuelo Pedrós, Antonia Agustí, et al.
Pageof 2